We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dunedin Enterprise Investment Trust Plc | LSE:DNE | London | Ordinary Share | GB0005776561 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-17.00 | -3.53% | 464.00 | 468.00 | 505.00 | 464.00 | 464.00 | 464.00 | 9,470 | 11:56:50 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 1.52M | 1.25M | 0.0950 | 48.84 | 60.95M |
TIDMDNE
RNS Number : 6255A
Dunedin Enterprise Inv Trust PLC
27 March 2017
Dunedin Enterprise Investment Trust PLC (the "Company")
Director Declaration
As required by Listing Rule 9.6.14(2), Dunedin Enterprise Investment Trust PLC hereby gives notification that Duncan Budge, chairman and non-executive director of the Company, has been appointed as a director of BioPharma Credit PLC.
For further information, please contact:
Dunedin LLP
Company Secretary
Telephone: 0131 225 6699
27 March 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNPGUGUWUPMGGM
(END) Dow Jones Newswires
March 27, 2017 07:03 ET (11:03 GMT)
1 Year Dunedin Enterprise Inves... Chart |
1 Month Dunedin Enterprise Inves... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions